[MRNA] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[MRNA] Moderna, Inc.
Announcement Date
23-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -156.37%
Quarter Report
MRNA's Result
MRNA's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 6,754,000 19,263,000 17,736,000 274,490 48,036 122,512 176,974 83.43%
PBT -3,942,000 9,575,000 13,285,000 -744,513 -514,716 -384,408 -255,996 57.69%
Tax 772,000 1,213,000 1,083,000 2,551 -695 326 -80 -
NP -4,714,000 8,362,000 12,202,000 -747,064 -514,021 -384,734 -255,916 62.47%
Tax Rate - -12.67% -8.15% - - - - -
Total Cost 11,468,000 10,901,000 5,534,000 1,021,554 562,057 507,246 432,890 72.61%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -69.80 43.41 68.80 -272.16 -1,070.07 -314.04 -144.61 -11.42%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -12.34 21.22 30.28 -1.96 -1.55 -4.74 -0.68 62.07%
EPS Diluted -12.34 20.10 28.31 -1.96 -1.55 -4.74 -0.68 62.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.